The Trump Administration’s Quiet Take Down Of Healthcare Safety Agency

On July 15 AHRQ Halted At Least 104 Grants

That’s as a result of for 27 years, the AHRQ has been the solely federal company targeted on supporting work and analysis into bettering the protection and high quality of healthcare—therefore the identify of the company. That’s fairly darn vital stuff for those who occur to have a human head and physique and thus require healthcare sooner or later in your life or no less than care about somebody who does. An evaluation performed by the company had estimated that within the 2014 to 2017 interval alone, AHRQ-funded research had saved round 20,500 deaths and $7.7 billion in healthcare prices.

Such research have included analysis on stopping and controlling healthcare-associated infections, lowering of medical errors, safely allotting medicines, measuring hospital high quality and creating know-how that may assist enhance the protection and expertise of sufferers. An estimated 250,000 to 400,000 folks within the U.S. die every year from preventable medical errors. And an estimated 75,000 to 99,000 die every year from healthcare-associated infections.

Nevertheless, with out AHRQ, these concerned about researching such areas might wrestle to seek out funding, particularly with what the Trump administration together with Elon Musk’s so-called Division of Authorities Effectivity have achieved to Nationwide Institutes of Well being and Facilities for Illness Management and Prevention funding. Subsequently, a July 15 letter from the AHRQ will need to have made a number of healthcare high quality and security researchers across the nation go “Argh”—telling them that AHRQ was halting no less than 104 of their grants.

AHRQ Had Gone A Yr With out Issuing New Grants

That’s after the AHRQ had gone over a yr with out issuing any new grants and spending lower than $15 million of the $345 million allotted by Congress to the company for the present fiscal yr. So until AHRQ someway finally ends up issuing, oh, $330 million in grants from now to September 30, the Trump administration can have principally ignored what Congress had wished and indicated, which wouldn’t be the primary time that’s occurred.

Final August, the Society for Basic Inner Drugs did provoke a lawsuit in opposition to AHRQ Director Roger Klein, MD, JD, and U.S. Secretary of Well being and Human Providers Robert F. Kennedy, Jr., JD over AHRQ’s not issuing new grants. The lawsuit alleges that such actions—or moderately inaction—violates a 1974 regulation that emphasizes that Congress and never the U.S. President and his Govt Brach in the end determines what federal companies can spend on what. Of observe, the July 15 grant-halting letter from AHRQ didn’t point out the T-word—that means “termination”—and as an alternative used the phrase “not awarded continued funding,” which can have ramifications in relation to what occurs to lawsuits just like the one initiated by SGIM.

HHS spokesperson Emily Hilliard has indicated that AHRQ has been aiming to ascertain a brand new “framework” for grants. Nevertheless, it’s not been clarified what this framework could be and when it could be revealed. I’ll proceed to succeed in out to contacts at HHS for extra clarification.

AHRQ Has Shed And Misplaced Three-Quarters Of Its Personnel

Within the meantime, for those who do attempt to name or in any other case attain out to AHRQ to ask questions on what’s occurring, good luck getting a response. The company has misplaced about three-quarters of its personnel since Donald Trump ascended to the U.S. Presidency in January 2025. These personnel losses have come by means of a variety of various firings, layoffs resignations and different so-called RIFs or reductions in forces. Those that have been at AHRQ informed me that by late 2025, the variety of empty chairs already far outnumbered the variety of folks at AHRQ conferences.

Trump Had Already Wished To Remove AHRQ Throughout His First Presidential Time period

What’s occurring proper now with AHRQ shouldn’t be a shock. Again in 2017, I wrote in Forbes about how the proposed price range being put forth by then first time period U.S. President Donald Trump and his administration had already tried to successfully get rid of AHRQ. Congress on the time, although, primarily handled this price range proposal like a pair of parachute pants and ignored it, leaving AHRQ with a price range.

The Trump-appointed Director Of AHRQ Has Not Been Spending The Funds That Congress Allotted

Nevertheless, throughout Trump’s second time period, his administration appears to have extra trump playing cards up its sleeve in relation to ignoring Congress when Congress ignores the Trump administration’s price range proposals. In 2025, the second coming of the Trump administration as soon as once more saved AHRQ out of its proposed price range, as I covered in Forbes. Congress as soon as once more ignored such a proposal and budgeted cash for AHRQ. This time, although, the Trump administration has apparently circumvented Congress by simply holding AHRQ from spending its Congressional allotted funds.

It stays to be seen whether or not the Trump administration will even maintain AHRQ as a separate company or dissolve it solely. Kennedy did announce in March 2025 plans to roll AHRQ and different HHS companies into a brand new Workplace of Technique. And Klein hasn’t actually made public statements to assist everybody clearly perceive the route of AHRQ for the reason that Trump administration appointed him in July 2025 to be the brand new AHRQ director. Klein’s AHRQ web site bio does lists him as “a board-certified molecular pathologist and legal professional who was previously Chief Medical Officer of OmniSeq, Inc., a tumor profiling firm that was acquired by LabCorp” however doesn’t point out a lot about his imaginative and prescient for healthcare high quality and security.

Traditionally, federal companies have included varied advisory committees of exterior scientific specialists to assist present extra transparency and oversight of its actions—particularly its funding ones. However actions like Trump’s executive orders and the new White House Office of Management and Budget rule that I’ve lined in Forbes have progressively lessened the function of scientific peer evaluate and different such exterior oversight in guiding federal company operations akin to grantsmaking. That’s concurrently elevated the facility of the President and his political appointees over what the federal companies do and the place the companies’ funding goes.

The difficulty is healthcare high quality and security work might seem to be one thing you may lower with out instantly clear ramifications—form of like chopping the White Home pandemic preparedness and response capabilities in 2017 and the food-borne sickness prevention and management applications in 2025. However ultimately the ramifications of such cuts can be seen, which is what occurred in 2020 with the COVID-19 pandemic and this yr with the 12 lively food-borne sickness outbreaks now occurring. And it’s secure to say that chopping work on healthcare security and high quality can have its ramifications down the highway.